By Bhanvi Satija Oct 2 (Reuters) – Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Novartis to develop messenger RNA-based therapies,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Karen Freifeld WASHINGTON, Nov 16 (Reuters) - The Trump administration said on Monday it…
THE STATE DEPARTMENT DAYBOOK Tuesday, November 17, 2026 ----- The daybook editor is Timothy Ryan…
REUTERS NEXT- CALIFORNIA CONSUMER WATCHDOG ROHIT CHOPRA SAYS BIG WORRY IS BIG LINKAGE BETWEEN AI…
VIDEO SHOWS: MATCH POINT FROM THE FINAL OF THE ATP FINALS DOUBLES WON BY HENRY…
By Karen Freifeld WASHINGTON, Nov 16 (Reuters) - The Trump administration said on Monday it…
By Karen Freifeld WASHINGTON, Nov 16 (Reuters) - The Trump administration said on Monday it…